Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis
Currently, treatment with disease-modifying therapies has limited impact on the progressive stages of multiple sclerosis. Stem-cell therapies have been claimed to be a possible treatment for patients with secondary progressive multiple sclerosis (SPMS). Leone MA et Al. in this phase I, open-label, multicenter, dose-escalation clinical trial of intracerebroventricular transplantation of allogeneic human neural stem/progenitor cells […]